Jia-Li Deng

Nanotherapeutic Strategies for MASLD: From Pathological Mechanisms to Targeted Delivery Systems

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive metabolic liver disorder driven by hepatic lipid overload, oxidative stress, mitochondrial dysfunction, innate immune activation, insulin resistance, gut–liver axis dysregulation, and liver fibrosis. These interconnected patholog...